n-(((4-benzoylamino)phenyl)sulfonyl)glycine has been researched along with probenecid in 1 studies
| Studies (n-(((4-benzoylamino)phenyl)sulfonyl)glycine) | Trials (n-(((4-benzoylamino)phenyl)sulfonyl)glycine) | Recent Studies (post-2010) (n-(((4-benzoylamino)phenyl)sulfonyl)glycine) | Studies (probenecid) | Trials (probenecid) | Recent Studies (post-2010) (probenecid) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 3,664 | 292 | 375 |
| Protein | Taxonomy | n-(((4-benzoylamino)phenyl)sulfonyl)glycine (IC50) | probenecid (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 8 | Mus musculus (house mouse) | 3.02 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 6.85 | |
| Solute carrier family 22 member 8 | Homo sapiens (human) | 6.965 | |
| Solute carrier family 22 member 8 | Rattus norvegicus (Norway rat) | 6.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayalasomayajula, SP; DeRuiter, J; Kompella, UB; Sunkara, G | 1 |
1 other study(ies) available for n-(((4-benzoylamino)phenyl)sulfonyl)glycine and probenecid
| Article | Year |
|---|---|
Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.
Topics: Adjuvants, Pharmaceutic; Animals; Brain; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Glycine; Linear Models; Male; Probenecid; Rats; Rats, Sprague-Dawley; Retina; Sulfones; Tissue Distribution | 2010 |